Meconium Aspiration Syndrome
Öz
Meconium-stained amniotic fluid occurs in approximately 13% of normal pregnancies and 5% of these infants develop meconium aspiration syndrome. Meconium aspiration syndrome is mostly a problem of term and postterm infants. There may be mild tachypnea or dispnea, respiratory insufficiency and persistant pulmonary hypertension in meconium aspiration syndrome. Meconium aspiration syndrome has a complex pathophysiology. Babies with meconium aspiration syndrome have both acute effects and long term morbidities such as bronchial reactivity and wheezing. Although there is improvement in pathophysiology and treatment modalities, it is still difficult to treat meconium aspiration syndrome. In this paper, management of newborns with meconium stained amniotic fluid and meconium aspiration syndrome in antenatal, natal and postnatal period are reviewed.
Anahtar Kelimeler
Kaynakça
- 1. Zhang X, Kramer MS. Variations in mortality and morbidity by gestational age among infants born at term. J Pediatr. 2009; 154: 358–62.
- 2. Dargaville PA, Copnell B. Australian and New Zelland Neonatal Network. The epidemiology of meconium aspiration syndrome: Incidence, risk factors, therapies, andoutcome. Pediatrics. 2006; 117: 1712-21.
- 3. Crowley MA. Neonatal Respiratory Disorders. In Fanaroff and Martin’s Neonatal-Perinatal Medicine, Diseases of the Fetus and Infant, 10th ed (Eds RJ Martin, AA Fanaroff, MC Walsh): 1137-46. Philadelphia, Elsevier Saunders, 2015.
- 4. Abu-Shaweesh JM. Respiratory Disorders in Preterm and Term Infants. In Fanaroff and Martin’s Neonatal Perinatal Medicine, Diseases of the Fetus and Infant 9th ed (Eds RJ Martin, AA Fanaroff, MC Walsh): 1141-70. Philadelphia, Mosby Elsevier 2011.
